CN102204610A - 一种银杏保健茶 - Google Patents
一种银杏保健茶 Download PDFInfo
- Publication number
- CN102204610A CN102204610A CN2011101842836A CN201110184283A CN102204610A CN 102204610 A CN102204610 A CN 102204610A CN 2011101842836 A CN2011101842836 A CN 2011101842836A CN 201110184283 A CN201110184283 A CN 201110184283A CN 102204610 A CN102204610 A CN 102204610A
- Authority
- CN
- China
- Prior art keywords
- tea
- leaf
- health
- ginkgo
- gingko
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 48
- 244000194101 Ginkgo biloba Species 0.000 title abstract description 48
- 235000013616 tea Nutrition 0.000 claims abstract description 30
- 235000018905 epimedium Nutrition 0.000 claims abstract description 25
- 240000000249 Morus alba Species 0.000 claims abstract description 21
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 21
- 235000009569 green tea Nutrition 0.000 claims abstract description 17
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 48
- 235000011201 Ginkgo Nutrition 0.000 claims description 47
- 241001016310 Epimedium grandiflorum Species 0.000 claims description 22
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 240000000171 Crataegus monogyna Species 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 235000014360 Punica granatum Nutrition 0.000 claims description 9
- 241000218628 Ginkgo Species 0.000 claims 9
- 244000294611 Punica granatum Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 24
- 239000002994 raw material Substances 0.000 abstract description 6
- 206010020772 Hypertension Diseases 0.000 abstract description 5
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 241000893536 Epimedium Species 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 229920003266 Leaf® Polymers 0.000 description 50
- 230000036541 health Effects 0.000 description 13
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 241000219991 Lythraceae Species 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 229930003944 flavone Natural products 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- -1 flavone compound Chemical class 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- IWEIJEPIYMAGTH-UHFFFAOYSA-N Bilobetin Chemical compound COC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 IWEIJEPIYMAGTH-UHFFFAOYSA-N 0.000 description 4
- 206010039966 Senile dementia Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical group O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- PPCHTBBOSVKORE-UHFFFAOYSA-N 3,5-dihydroxy-2-(4-methoxyphenyl)-8,8-dimethyl-9,10-dihydropyrano[2,3-h]chromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C3OC(C)(C)CCC3=C2O1 PPCHTBBOSVKORE-UHFFFAOYSA-N 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229930184727 ginkgolide Natural products 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- SLCKJKWFULXZBD-ZOTFFYTFSA-O pelargonin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=[O+]C1=CC(O)=C2)C=3C=CC(O)=CC=3)=CC1=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 SLCKJKWFULXZBD-ZOTFFYTFSA-O 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-LQSBFMDOSA-N 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-LQSBFMDOSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000424773 Epimedium alpinum Species 0.000 description 1
- 241001362411 Epimedium sagittatum Species 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241001113926 Gelsemium Species 0.000 description 1
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 241000208278 Hyoscyamus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 241000218394 Magnolia liliiflora Species 0.000 description 1
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241001083505 Punica Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000743 anti-peroxide Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种银杏保健茶，主要原料有银杏叶、绿茶，其特征在于还有淫羊霍、桑叶。将淫羊霍、桑叶与银杏叶和绿茶配伍，能使银杏叶的保健、治疗效果得到互补，其效果成倍增长，对心血管疾病、糖尿病患者特别是伴有高血压患者的应用，比单一银杏叶的银杏茶有效时间大幅缩短，因而可以减少饮用时间，同时减少饮用者的经济负担。
Description
技术领域
本发明涉及一种以银杏叶为主料配有茶叶和其它具有天然成分的淫羊藿、桑叶等组成的保健茶，属于饮品技术领域。具体地说是一种银杏为主原料的保健茶。
背景技术
银杏叶的医药保健价值已被国内外学者所揭示，银杏叶含有20多种黄酮类化合物，其含量在总提取物中大于24％，主要有银杏双酮(Cinkgetin)、异银杏双黄酮(So ginkgetin)、白果黄素(Bilobetin)。银杏叶中还含有萜内酯类化合物，二萜内酯主要有银杏内酯(Ginkgolide)A、B、C、M、J等，倍半萜内酯即白果内酯(Bilobalide)。此外，还含有酚类、25种有益元素、17种氨基酸、生物碱等。现代研究具有改善心脑血管功能、平喘、扩张冠脉、抗心肌缺血、扩张血管、降压、抗血小板活化因子、抑制血小板聚集、延缓衰老、增强免疫功能、改善学习记忆功能、抗炎、保肝、降血酯、抗癌等作用。现代应用被作为冠心病、脑卒中、高脂血症、糖尿病、支气管哮喘、慢性气管炎等疾病的治疗剂，效果明显(沈映君，等·中药药理学·人民卫生出版社，2006，1040-1047)。目前国内外医药科学家们的临床实验已证明，银杏叶保健茶是治疗脑血管和心血管动脉硬化、高血压、糖尿病、老年性痴呆的新型保健茶。根据报道资料显示现有的银杏茶技术中，多由单一银杏叶或银杏叶提取物以及多物料组配而成。适当的多物组配可以起到功效互补的作用，使其在短时间内显示出明显的效果，有/或使之功效倍增的优点。已有专利文献中公开了一些多物组配的技术方案，如：
93102087.5银杏茶及制作方法原料：银杏叶、茶叶。
94007415.8银杏系列袋泡茶原料：银杏叶、山楂叶、人参叶。
96108682.3一种具有防治脉硬化作用的三叶保健茶原料：银杏叶、荷叶、柿叶、枸杞子、大枣、山楂、玉米须、芡实、芝麻。
01109612.8刺玫银杏茶原料：刺玫果、刺玫提取物、银杏叶、茶叶。
20061006873.X一种银杏养生茶及其制备方法原料：银杏叶、绞股蓝、灵芝、绿茶。
本发明的目的在于提供一种富含黄酮化合物、多糖等有机成分的天然植物的叶，组成银杏保健茶，使之具有协同作用，充分发挥其保健效果的作用，使之达到功效倍增的优点。
发明内容
本发明的目的在于提供一种具有调节血脂、降低血糖，同时具有促进人体新陈代谢，增强机体免疫力，降低血清胆固醇，延缓肌体衰老的一种银杏保健茶，目的还在于它具有协同作用，充分发挥其保健、防治效果的作用，使其发挥功效倍增的优势。
本发明的技术方案是：一种银杏保健茶，其特征在于它主要由：银杏叶40-70％、绿茶10-20％、淫羊藿5-15％、桑叶5-15％组成，其特征在于还有淫羊藿、桑叶组成，各组成份的重量百分比为：各组份含量之和为100％。
如上所述的一种银杏保健茶，其特征在于它由：银杏叶40-60％、绿茶10-15％、淫羊藿10-15％、桑叶5-10％、枸杞叶5-10％组成，各组成份含量之和为100％。
如上所述的一种银杏保健茶，其特征在于它由：银杏叶40-65％、绿茶10-15％、淫羊藿10-15％、桑叶5-10％、枸杞叶5-10％、石榴叶5-10％组成，各组成份含量之和为100％。
如上所述的一种银杏保健茶，其特征在于它由：银杏叶40-60％、绿茶10-15％、淫羊藿5-10％、桑叶5-10％、枸杞叶2.5-5％、石榴叶2.5-5％、山楂叶10-15％组成，各组成份含量之和为100％。
本发明的一种银杏保健茶，将淫羊藿、桑叶与银杏叶和绿茶配伍，能使银杏叶的保健、治疗效果得到互补，其效果成倍增长，对心血管疾病、糖尿病患者特别是伴有高血压患者的应用，比单一银杏叶的银杏茶有效时间大幅缩短，因而可以减少饮用时间，同时减少饮用者的经济负担。
在本发明的配方中，淫羊藿为小檗科植物淫羊藿Epimedium brtvicornum Maxim.、箭叶淫羊藿Epimedium Sagittatum Maxim、柔毛淫羊藿Epiaedium Pubescens Maxim的干燥地上部分的茎叶。本品含淫羊藿苷(Icariine)、去氧甲基淫羊藿苷(Des-O-methy-icariine)、β-去氢淫羊藿素(β-anhydroicaritine)，还含有木兰素、异槲皮素和金丝桃苷等。淫羊藿味辛、甘、性温。归肝、肾经。现代药理研究(沈映君，中药药理学.人民卫生出版社，2006，08，第一版(5)904-907)表明淫羊藿具有温肾壮阳补气益精功效，对心血管系统具有强心作用、抗心肌缺血、降血压、抗心律失常以及抗菌、抗病毒作用，现代医学用于冠心病、高血压、神经衰弱的治疗。具(贾公孚，临床药物新用联用大全.人民卫生版社，2006，12，(2)：1237-1238)药理研究淫羊藿有①雄激素样作用；②调节免疫功能；③镇静，催眠，抗疲劳，抑制丘脑单胺氧化酶活性；④降血压、降血糖、降血脂作用；⑤抑制心肌收缩，保护心肌，降低心肌耗氧量；⑥降低血粘度，抑制血小板聚集，抗血栓。增加脑血流量，降低脑血管阻力，改善脑缺血和缺氧；⑦抗病原微生物，抑制肠道病毒；⑧抗肿瘤作用；⑨降低骨吸收，增加骨形成和矿化沉积率；⑩改善造血系统障碍，增加白细胞、骨髓造血干细胞的粒单系祖细胞数量；(11)抗衰老作用，抗过氧化物。
淫羊藿被国家卫生部列入《可用于保健食品的物品名单》，可作为保健食品使用。
在本发明的配方中，桑叶(Morus albaL.)甘、苦、寒。归肺、肝经。具疏风散热，清肺润燥，清肝明目。现代化学研究证明桑叶含有黄酮及黄酮苷、多糖、甾醇、挥发油、氨基酸、维生素B1、胆碱等多种对人体健康有益的有效成分，药理研究表明，桑叶对人体极为安全，具有降血糖、降血脂、抗炎、抗衰老、抗病毒等多种治疗功能。
本发明的银杏保健茶，在主方的基础上增配不同原料还可以使之保健和治疗效果中的某一特性显著提高。
增配枸杞叶，可以起到清热解毒养颜，补肾壮阳，明目安神，除烦止渴，改善睡眠，增强人体免疫功能，降血脂、降血糖的辅助疗效。
配方中枸杞叶，又名“天精草”，苦、甘、平、无毒。归心、肺、脾、肾经。具补虚益精、清热止渴、明目养颜。现代科学研究表明枸杞叶中含有β-谷甾醇(β-D)葡萄糖甙、芦丁、维生素B1、B2、C、东茛菪素(Scopoletin)、甜菜碱、氨基酸、生物总黄酮等，具有益补肝、肾功效。枸杞叶中还富含多酚类物质，使其具有良好的抗氧化功能，有益于抗衰老和增强人体免疫力。
增配石榴叶，利用其具有收敛止泻、消炎止血的功效，有助于眼睛及胃的保健、调节内分泌等功效，有助于胃肠功能不好的人群使用。
配方中石榴叶为安石榴科安石榴属植物石榴(Punica granatumL.)的叶，性平、温、味甘涩，具有收敛止泻、消炎止血功效。现代研究表明，石榴叶含有黄酮类化合物、鞣质、鞣花酸、谷甾醇、生物碱、天竺葵甙、乌索酸、山楂酸、积雪草酸等成分。主要作用有：治疗急性胃肠炎，慢性前列腺炎，增强心血管功能，延缓衰老，抗肿瘤，增强免疫力，调节内分泌等。
增配山楂叶，对于血瘀气滞、心季健忘、眩晕耳鸣的患病人群更有较好地辅助治疗功效，山楂叶水浸液有明显的利尿作用，且作用温和缓慢而持久，对伴有高血压病的高血脂患者更有利于治疗。
配方中山楂叶，酸、平。归肝经。具有活血化瘀，理气通脉，化浊降脂功能。用于气滞血瘀，胸痹心痛，胸闷憋气，心悸健忘，眩晕耳鸣，高血脂症。现代研究表明，山楂叶富含黄酮成分，包括金丝桃甙、槲皮素、黄酮聚合物等，另外尚含有绿原酸、山楂酸、内酯、熊果酸等成分。对高血压，高血脂，冠心病心绞痛，关节痛，水肿等病人治疗效果好。
本发明的实施例如下：
实施例一、
银杏叶60 绿茶20 淫羊藿10 桑叶10
实施例二、
银杏叶55 绿茶15 淫羊藿10 桑叶10 枸杞叶10
实施例三、
银杏叶55 绿茶10 淫羊藿10 桑叶5 枸杞叶10 石榴叶10
实施例四、
银杏叶45 绿茶15 淫羊藿10 桑叶5 枸杞叶5 石榴叶5 山楂叶15
本发明的银杏保健茶，除上述优点外，还具有价格便宜，充分利用植物资源的优点，特别发挥物料成份互补的协同效果，使其发挥多种功效。是茶中的精品。
Claims (4)
1.一种银杏保健茶，其特征在于它主要由银杏叶、绿茶、淫羊藿、桑叶组成，各组份的重量百分比为：银杏叶40-70％、绿茶10-20％、淫羊藿5-15％、桑叶5-15％组成，各组成份含量之和为100％。
2.一种银杏保健茶，其特征在于它由：银杏叶40-60％、绿茶10-15％、淫羊藿10-15％、桑叶5-10％、枸杞叶5-10％组成，各组成份含量之和为100％。
3.一种银杏保健茶，其特征在于它由：银杏叶40-65％、绿茶10-15％、淫羊藿10-15％、桑叶5-10％、枸杞叶5-10％、石榴叶5-10％组成，各组成份含量之和为100％。
4.一种银杏保健茶，其特征在于它由：银杏叶40-60％、绿茶10-15％、淫羊藿5-10％、桑叶5-10％、枸杞叶2.5-5％、石榴叶2.5-5％、山楂叶10-15％组成，各组成份含量之和为100％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110184283 CN102204610B (zh) | 2011-06-28 | 2011-06-28 | 一种银杏保健茶 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110184283 CN102204610B (zh) | 2011-06-28 | 2011-06-28 | 一种银杏保健茶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102204610A true CN102204610A (zh) | 2011-10-05 |
| CN102204610B CN102204610B (zh) | 2013-02-13 |
Family
ID=44693886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110184283 Expired - Fee Related CN102204610B (zh) | 2011-06-28 | 2011-06-28 | 一种银杏保健茶 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102204610B (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626151A (zh) * | 2012-04-11 | 2012-08-08 | 徐州绿之野生物食品有限公司 | 一种银杏叶提取工艺及银杏绿茶的加工方法 |
| CN103622113A (zh) * | 2013-12-12 | 2014-03-12 | 胡敏 | 一种鼠曲草饮料 |
| CN104223053A (zh) * | 2013-06-20 | 2014-12-24 | 唐贝宁医药科技（北京）有限公司 | 一种同步降低高血糖高血压高血脂的新型功能性食品 |
| CN105663445A (zh) * | 2016-02-18 | 2016-06-15 | 厦门特伦生物药业有限公司 | 一种防治心脑血管疾病的降三高茶核酸生产工艺 |
| CN105920057A (zh) * | 2016-06-03 | 2016-09-07 | 通化师范学院 | 一种淫羊藿苷的用途 |
| CN106172967A (zh) * | 2016-06-28 | 2016-12-07 | 林荣坤 | 一种复合茶及其制备方法 |
| CN107865279A (zh) * | 2017-11-08 | 2018-04-03 | 徐州工程学院 | 银杏石榴叶红茶饮料及其制备方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1232690A (zh) * | 1998-12-17 | 1999-10-27 | 童忠良 | 银杏沙棘养生茶 |
| CN1416714A (zh) * | 2002-12-06 | 2003-05-14 | 广东益万家食品有限公司 | 银杏桑叶茶 |
| CN1586255A (zh) * | 2004-09-07 | 2005-03-02 | 桑映辉 | 一种保健茶 |
| CN1868532A (zh) * | 2005-05-23 | 2006-11-29 | 邓大勇 | 一种治疗高血压病的药物 |
| CN1935178A (zh) * | 2005-09-06 | 2007-03-28 | 蔡军 | 银杏叶提取物与淫羊藿提取物的组合物 |
| CN101731398A (zh) * | 2008-11-20 | 2010-06-16 | 张立全 | 一种银杏叶花茶 |
-
2011
- 2011-06-28 CN CN 201110184283 patent/CN102204610B/zh not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1232690A (zh) * | 1998-12-17 | 1999-10-27 | 童忠良 | 银杏沙棘养生茶 |
| CN1416714A (zh) * | 2002-12-06 | 2003-05-14 | 广东益万家食品有限公司 | 银杏桑叶茶 |
| CN1586255A (zh) * | 2004-09-07 | 2005-03-02 | 桑映辉 | 一种保健茶 |
| CN1868532A (zh) * | 2005-05-23 | 2006-11-29 | 邓大勇 | 一种治疗高血压病的药物 |
| CN1935178A (zh) * | 2005-09-06 | 2007-03-28 | 蔡军 | 银杏叶提取物与淫羊藿提取物的组合物 |
| CN101731398A (zh) * | 2008-11-20 | 2010-06-16 | 张立全 | 一种银杏叶花茶 |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626151A (zh) * | 2012-04-11 | 2012-08-08 | 徐州绿之野生物食品有限公司 | 一种银杏叶提取工艺及银杏绿茶的加工方法 |
| CN104223053A (zh) * | 2013-06-20 | 2014-12-24 | 唐贝宁医药科技（北京）有限公司 | 一种同步降低高血糖高血压高血脂的新型功能性食品 |
| CN103622113A (zh) * | 2013-12-12 | 2014-03-12 | 胡敏 | 一种鼠曲草饮料 |
| CN103622113B (zh) * | 2013-12-12 | 2014-09-17 | 胡敏 | 一种鼠曲草饮料 |
| CN105663445A (zh) * | 2016-02-18 | 2016-06-15 | 厦门特伦生物药业有限公司 | 一种防治心脑血管疾病的降三高茶核酸生产工艺 |
| CN105920057A (zh) * | 2016-06-03 | 2016-09-07 | 通化师范学院 | 一种淫羊藿苷的用途 |
| CN106172967A (zh) * | 2016-06-28 | 2016-12-07 | 林荣坤 | 一种复合茶及其制备方法 |
| CN107865279A (zh) * | 2017-11-08 | 2018-04-03 | 徐州工程学院 | 银杏石榴叶红茶饮料及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102204610B (zh) | 2013-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102204610B (zh) | 一种银杏保健茶 | |
| KR100998225B1 (ko) | 녹용, 산수유, 당귀, 구기자, 산약, 진피, 천마, 배초향, 계피, 홍삼, 및 오미자의 추출물을 유효성분으로 포함하는 면역증강 조성물 | |
| CN101317615B (zh) | 一种银棘茶饮料及其制备方法 | |
| CN1846764A (zh) | 一种保健药酒 | |
| CN101161117A (zh) | 具有降血压和改善心脑血管功能的营养保健品及制备方法 | |
| CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
| CN105079465A (zh) | 一种降低血糖的组合物 | |
| CN106562413A (zh) | 一种提高免疫力膏滋及其制备方法 | |
| CN101919476A (zh) | 黄精山楂袋泡茶及其制备方法 | |
| CN102161961B (zh) | 一种保健酒及其制备方法 | |
| CN103828983A (zh) | 一种杜仲保健茶 | |
| CN102823654A (zh) | 系列中药保健奶片及其制备方法 | |
| CN104857154A (zh) | 一种治疗“三高”症的中药组合物及其制备方法 | |
| CN107114781B (zh) | 一种用于保肝的保健食品及其制备方法 | |
| CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
| CN102161960B (zh) | 一种美容调节酒 | |
| CN102604802B (zh) | 一种原生态竹锗营养酒的制备方法 | |
| CN108785370A (zh) | 一种用于治疗高血脂症及动脉粥样硬化的药物组合物 | |
| CN103053744A (zh) | 绞股蓝竹叶茶及其生产方法 | |
| CN102823700A (zh) | 一种复方茯苓黑大蒜夹心巧克力的制备方法 | |
| CN102613648B (zh) | 一种原生态竹锗营养液的制备方法 | |
| CN105533006A (zh) | 茶配方及其制备方法 | |
| CN103725587A (zh) | 黄精山楂醋及其生产方法 | |
| CN1044965C (zh) | 沙梨保健饮料 | |
| CN106615452A (zh) | 一种杜仲保健茶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG ZHINIAN Effective date: 20130107 Owner name: XUZHOU LVZHIYE BIOLOGICAL FOOD CO., LTD. Free format text: FORMER OWNER: ZHANG ZHINIAN Effective date: 20130107 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhinian Inventor after: Zhang Kuichang Inventor before: Zhang Kuichang Inventor before: Zhang Zhinian |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG KUICHANG ZHANG ZHINIAN TO: ZHANG ZHINIAN ZHANG KUICHANG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130107 Address after: 221354, Jiangsu, Pizhou Province sheep town on the eastern side of the road Applicant after: Xuzhou Lvzhiye Biological Food Co., Ltd. Applicant after: Zhang Zhinian Address before: 221354, 88, Pizhou Town, Jiangsu Province sheep town government dormitory Applicant before: Zhang Zhinian |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: ZHANG ZHINIAN Effective date: 20130207 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20130207 Address after: 221354, Jiangsu, Pizhou Province sheep town on the eastern side of the road Patentee after: Xuzhou Lvzhiye Biological Food Co., Ltd. Address before: 221354, Jiangsu, Pizhou Province sheep town on the eastern side of the road Patentee before: Xuzhou Lvzhiye Biological Food Co., Ltd. Patentee before: Zhang Zhinian |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130213 Termination date: 20200628 |